Alder Hey Children's NHS Foundation Trust
35
7
8
10
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 60/100
8.6%
3 terminated/withdrawn out of 35 trials
76.9%
-9.6% vs industry average
11%
4 trials in Phase 3/4
20%
2 of 10 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (35)
Advanced MRI in IVH
Role: collaborator
Exploring and Measuring the Impact of Steroids in Children and Young People
Role: collaborator
An Exploratory Physiological Study of Post-operative Recovery in Surgical Neonates and Dimethylarginine:Arginine Levels
Role: collaborator
Effective Dosing of Burosumab in XLH
Role: collaborator
Calprotectin and Gut Disease Study
Role: collaborator
Adalimumab in JIA-associated Uveitis Stopping Trial
Role: collaborator
Early Diagnosis of SSc in the General Rheumatology Clinic - Pilot
Role: collaborator
Developing Allogeneic Musculoskeletal Therapies
Role: collaborator
The LAVA (Lateral Flow Antigen Validation and Applicability) Study for COVID-19
Role: lead
Hirschsprung's Advances; Working Towards Autologous tIssue therapIes
Role: lead
Babies With Enterocolitis - A Study of Faecal Calprotectin in Hirschsprung Disease (The BEACH Study)
Role: lead
Closed Loop From Onset in Type 1 Diabetes
Role: collaborator
PlayPhysio: Making Physio Fun
Role: lead
PLAY Therapy Intervention: Re-Modelling Patient Experience (The PLAYTIME Study)
Role: lead
Long-term Qualitative and Quantitative Outcomes of Children With Hirschsprung's Disease and Anorectal Malformations
Role: lead
Evaluation of Faecal Volatile Organic Compounds in the Diagnosis of Paediatric Inflammatory Bowel Disease
Role: lead
ENHANCE- Establishing Natural History in an Advanced New CF Care Era
Role: collaborator
The National Transition Evaluation Study
Role: collaborator
FASter Insulin in Closed-loop Technology in Children
Role: collaborator
The LAVA (Lateral Flow Antigen Validation and Applicability) 2 Study for COVID-19
Role: lead